The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

11 Nov 2013 12:28

RNS Number : 7084S
ABCAM Plc
11 November 2013
 



For immediate release

11 November 2013

 

ABCAM PLC

("Abcam" or "the Company")

Director dealing

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of protein research tools, was notified today that on 8 November 2013, Jeff Iliffe, an Executive Director of the Company, transferred 234,650 ordinary shares of 0.2 pence each in the Company (Ordinary Shares) to his wife, Keren Williams for nil consideration.

Following these transactions, Mr Iliffe's total beneficial interest in the Company remains unchanged at 274,480 Ordinary Shares, representing approximately 0.14 per cent of the current issued share capital of the Company. 

 

For further information please contact:

Abcam

+ 44 (0) 1223 696 000

Jeff Iliffe, Chief Financial Officer

 

Numis Securities - Nominated Adviser & Joint Broker

+ 44 (0) 20 7260 1000

Michael Meade - Nominated Adviser

James Black - Corporate Broking

 

Peel Hunt LLP - Joint Broker

+ 44 (0) 20 7418 8900

Andy Crossley - Corporate Broking

 

Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Fiona Henson / Sophie Cowles

 

Notes for editors:

About Abcam plc

Abcam plc is a leading provider of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse cells at the molecular level to improve the understanding of health and disease.

Abcam is committed to providing scientists with access to the correct reagents and tools for their research. The Company's catalogue currently comprises more than 124,500 products and is continually evolving to meet customer needs. The range offered includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam products are supported with detailed, up-to-date and unbiased data on our website.

Headquartered in Cambridge, UK, Abcam has eight global subsidiary offices and ships to over 100 countries. The Company was founded in 1998, and now employs over 700 people. Abcam is quoted on the AIM market of the London Stock Exchange (AIM: ABC).

To find out more, please visit www.abcam.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLFLFFXFFLFBQ

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.